Approval · Notice of Compliance 16699 · 2015
SIVEXTRO: Notice of Compliance 16699
Issued March 17, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16699
- Date
- March 17, 2015
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antibacterial agent
Products in this notice
Medicinal ingredients
- TEDIZOLID PHOSPHATE 200 MG per TAB
- TEDIZOLID PHOSPHATE 200 MG per VIAL